-
Study aim
-
Evaluation of the effectiveness and satisfaction of fractional co2 laser and stromal vascular fraction (SVF) in the treatment of burn scar
-
Design
-
The clinical trial, with parallel groups, double-blind, simple randomized by sealed envelopes, phase 2-3 on 10 patients
-
Settings and conduct
-
The intervention will be performed at the Skin and Stem Cell Research Center. In this study, 10 patients with burn scars will be selected. Patients will receive 3 sessions of fractional CO2 laser treatment with an interval of one month. At the end of the first and third sessions, the SVF will be injected into the selected scar as the treatment group and the physiological serum will be injected at the other scar as the control group. The patient, the outcome assessor, and the data analyst are unaware of the type of intervention performed on each burn scar.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: skin type 1-4, atrophic burn scars in more than one limb from five years ago to the last 3 months.
Exclusion criteria: Age under 18 years, Laser treatment in the last three months, Active colloidal scar at the injection site, Coagulation and platelet disorders or a history of taking anticoagulants, Underlying diseases such as diabetes and autoimmune connective tissue disease that affect the wound healing process, Active viral infections, History of malignancy or receiving chemotherapy, Pregnancy, Lactation
-
Intervention groups
-
In each patient, three sessions of fractional carbon dioxide laser will be performed on each burn scar every one month. At the end of the first and third session, the stromal vascular fraction will be injected into one of the scars as the treatment group, another scar of the same patient will be injected the physiological serum as the control group.
-
Main outcome variables
-
The effectiveness of treatment, patient satisfaction, physician satisfaction